Answers are grounded in this paper and cite their sources.
An 81-day growth study evaluated the supplementing effects of a functional palatability enhancer (FPE) in a low fish meal (FM) diet on growth performance, feed efficiency, nutrient deposition, immune response, total count of bacteria and Vibrio sp. in the hepatopancreas and intestine, as well as hepatopancreatic morphology of Pacific white shrimp ( Penaeus vannamei ). Six diets were tested: a control diet formulated with 15% FM and no FPE; a basal diet with 7.5% FM and no FPE; and a basal diet supplemented with graded levels of FPE (0.075%, 0.1%, 0.125%, and 0.15%). Data were analyzed using one-way ANOVA followed by Tukey's multiple comparison test to determine dose–response relationships. The results show that reducing fish meal leads to a decrease in final mean weight (FMW), thermal growth coefficient (TGC), average daily growth (ADG), survival, protein deposition, total hemocyte count (THC), lysozyme activity (Lys), superoxide dismutase activity (SOD), and histomorphological condition, and an increase in feed conversion ratio (FCR) as well as the number of Vibrio sp. in shrimp fed the basal diet compared to the control diet. Adding FPE to the basal diet improved shrimp growth and health condition. The inclusion of 0.125% FPE led to significantly higher biomass, FMW, TGC, ADG, protein deposition, THC, Lys, and SOD than the control and other dietary treatments. FPE also improved hepatopancreatic morphology compared with the basal diet and showed no abnormal changes compared with the control group. Although shrimp fed 0.15% FPE showed better growth performance and health than the control treatment, performance declined compared with 0.125% FPE. These results demonstrate FPE's potential as a functional additive to enhance the attractability of the low-FM diet and that the proper inclusion level of FPE is crucial for optimizing feed attractability, which determines shrimp growth, nutrient deposition, immune function, and health.
No takes yet. Share an insight, caveat, or question.
Novriadi et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: